Let's Build Something Extraordinary Together

We work with early-stage biotech and pharma companies, academic spinouts exploring commercialization, AI-enabled drug discovery platforms, and life sciences venture capital firms and their portfolio companies. Whether you are pre-seed or scaling toward the clinic, we tailor our support to where you are in your journey.

Typically within 5 business days. We start with a structured operational assessment to identify priorities, then align with the client and their team before moving into execution. No lengthy scoping processes.

Engagements range from short-term operational due diligence projects (2–4 weeks) to ongoing fractional program leadership (6–12 months). Billing is flexible and can be structured as project-based, retainer, or hourly depending on the scope and needs of the engagement.

Yes. We are headquartered in Singapore and work with organizations across the US, Europe, and Asia. Our experience spans both US and international development frameworks, and we regularly support companies navigating cross-border regulatory and operational complexities. Time zone and location are not barriers to getting started.

We have experience across multiple therapeutic areas and modalities including oncology, CNS, rare disease, immunology, cell and gene therapy, and infectious disease. Our operational and program management expertise applies across indications, as the governance, milestone planning, and cross-functional coordination challenges are fundamentally similar.

Yes, completely free and no-obligation. We use the 30-minute call to understand your situation, share our honest assessment of where we could add value, and determine if there's a good fit. If there is, we'll outline a proposed scope. If not, we'll point you in the right direction.